15-66479669-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002755.4(MAP2K1):​c.569-2086C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.278 in 151,928 control chromosomes in the GnomAD database, including 6,504 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.28 ( 6504 hom., cov: 31)

Consequence

MAP2K1
NM_002755.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.534

Publications

20 publications found
Variant links:
Genes affected
MAP2K1 (HGNC:6840): (mitogen-activated protein kinase kinase 1) The protein encoded by this gene is a member of the dual specificity protein kinase family, which acts as a mitogen-activated protein (MAP) kinase kinase. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals. This protein kinase lies upstream of MAP kinases and stimulates the enzymatic activity of MAP kinases upon wide variety of extra- and intracellular signals. As an essential component of MAP kinase signal transduction pathway, this kinase is involved in many cellular processes such as proliferation, differentiation, transcription regulation and development. [provided by RefSeq, Jul 2008]
MAP2K1 Gene-Disease associations (from GenCC):
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • cardiofaciocutaneous syndrome 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp
  • Noonan syndrome with multiple lentigines
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, ClinGen
  • Noonan syndrome
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • Costello syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.354 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAP2K1NM_002755.4 linkc.569-2086C>T intron_variant Intron 5 of 10 ENST00000307102.10 NP_002746.1 Q02750-1A4QPA9
MAP2K1NM_001411065.1 linkc.425-2086C>T intron_variant Intron 4 of 9 NP_001397994.1
MAP2K1XM_011521783.4 linkc.503-2086C>T intron_variant Intron 5 of 10 XP_011520085.1 B4DFY5
MAP2K1XM_017022411.3 linkc.491-2086C>T intron_variant Intron 4 of 9 XP_016877900.1 Q02750-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAP2K1ENST00000307102.10 linkc.569-2086C>T intron_variant Intron 5 of 10 1 NM_002755.4 ENSP00000302486.5 Q02750-1

Frequencies

GnomAD3 genomes
AF:
0.278
AC:
42255
AN:
151808
Hom.:
6498
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.148
Gnomad AMI
AF:
0.284
Gnomad AMR
AF:
0.326
Gnomad ASJ
AF:
0.236
Gnomad EAS
AF:
0.314
Gnomad SAS
AF:
0.367
Gnomad FIN
AF:
0.297
Gnomad MID
AF:
0.222
Gnomad NFE
AF:
0.337
Gnomad OTH
AF:
0.284
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.278
AC:
42284
AN:
151928
Hom.:
6504
Cov.:
31
AF XY:
0.279
AC XY:
20745
AN XY:
74236
show subpopulations
African (AFR)
AF:
0.148
AC:
6131
AN:
41458
American (AMR)
AF:
0.327
AC:
4984
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.236
AC:
818
AN:
3468
East Asian (EAS)
AF:
0.315
AC:
1623
AN:
5148
South Asian (SAS)
AF:
0.368
AC:
1772
AN:
4818
European-Finnish (FIN)
AF:
0.297
AC:
3127
AN:
10542
Middle Eastern (MID)
AF:
0.224
AC:
66
AN:
294
European-Non Finnish (NFE)
AF:
0.337
AC:
22902
AN:
67920
Other (OTH)
AF:
0.286
AC:
602
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1504
3008
4512
6016
7520
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
438
876
1314
1752
2190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.314
Hom.:
6618
Bravo
AF:
0.274
Asia WGS
AF:
0.312
AC:
1089
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.92
DANN
Benign
0.68
PhyloP100
-0.53
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4255740; hg19: chr15-66772007; API